MSS-only trial: Immunotherapy: Nivo (Opdivo) + Antibody DS-8273a

Please feel free to read, share your thoughts, your stories and connect with others!
User avatar
Maia
Posts: 2216
Joined: Fri Aug 24, 2012 8:00 am

MSS-only trial: Immunotherapy: Nivo (Opdivo) + Antibody DS-8273a

Postby Maia » Wed Dec 28, 2016 8:01 pm

Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer

*Only mismatch repair (MMR)-proficient (=MSS) advanced colorectal cancer.
*Antibody DS-8273a + Nivolumab (=agonistic TRAIL-R antibody DS-8273a + anti-PD-1)
*DS-8273a: decrease in myeloid-derived suppressive cells (MDSC)
*Columbia and Texas; some locations still not recruiting
*a phase I trial in Solid tumours and Lymphoma (Late stage disease) completed 2015 (NCT02076451)

https://clinicaltrials.gov/ct2/show/NCT02991196

December 2, 2016: Selective targeting of myeloid-derived suppressor cells in cancer patients using DS-8273a, an agonistic TRAIL-R2 antibody J. Bendell et al. https://drive.google.com/open?id=0Bwc5k ... 20xOHl1U2M

Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”



Who is online

Users browsing this forum: Google [Bot], LB10, Yahoo [Bot] and 32 guests